<?xml version="1.0" encoding="ISO-8859-1" ?><rss version="2.0"><channel><title>ecancermedicalscience Policy Documents RSS Feed</title><link>http://www.ecancermedicalscience.com/</link><description>This RSS feed lets you know when new articles are added to the ecancermedicalscience website.</description><webMaster>dev@2cs.com;lowens@brandcastmedia.com;linda.cairns@ifom-ieo-campus.it;gordon.mcvie@ieo.it;jonathan@ecancermedicalscience.com;hannah@ecancermedicalscience.com;susi@ecancermedicalscience.com;susi.burke@cancerintelligence.com</webMaster><language>en</language><item><title>Eurocan Plus Report: Feasibility Study for Coordination of National Cancer Research Activities</title><link>http://www.ecancermedicalscience.com/view-article.asp?doi=10.3332/eCMS.2008.84</link><pubdate>Tue, 20 May 2008 00:00:00 GMT</pubdate><description><![CDATA[The process that resulted in the submission and funding of the Eurocan+Plus Project by the 6th Framework Programme was initiated by the European Parliament.<br/><br/>This report summarises the key findings and conclusions of the Eurocan+Plus Project which ran between October 2005 and December 2007, and outlines proposals for action in the short and the longer term.<br/><br/>Participants in the Project represented themselves and not the institution where they work. The Project was in no way a formal collaboration between any governmental body, funding agency, research or medical institution of any of the 27 EU Member States. In this respect, proposals in this Summary Report and in other deliverables in no way represent a formal commitment ofany governmental or non-governmental institution for any idea proposed by the Project.<br/><br/>For more information on the topics developed in this report, interested readers are invited to consult the reports issued by the different Work Packages. These reports can be consulted on the Project website www.eurocanplus.eu.]]></description></item><item><title>Policy Challenges for Cancer Research: A Call to Arms</title><link>http://www.ecancermedicalscience.com/view-article.asp?doi=10.3332/eCMS.2007.53</link><pubdate>Tue, 18 Sep 2007 00:00:00 GMT</pubdate><description><![CDATA[Research has delivered remarkable benefits for cancer patients and their families since James Watson and Francis Crick wrote the now immortal line, "We wish to propose a structure for the salt of deoxyribonucleic acid" thus setting the molecular foundations for the modern era of cancer control.  The pace of technological innovation from fundamental scientific discoveries to the policy impact of huge population studies has been breathtaking. One has only to contrast a paper on the treatment of solid epithelial cancers written by Henri Tagnon and colleagues in 1966  with the myriad of chemotherapeutic approaches at the oncologists disposal today. Inevitably, as the tide of research has risen so it has bought the flotsam and jetsam of regulations and policies. Some have been helpful, many pointless and too many actually harmful. Naturally some of these regulatory and general policies (by this I mean those concerned with funding, structure and organisation) have been specifically targeted at cancer research, e.g. US National Cancer Act 1971, whilst others have been a product of the general regulatory environment with indirect consequences for cancer research, e.g. EU Data Protection Directive 1995. Policy issues thus cover a vast terrain criss-crossed by complex interdependencies between scientific areas, countries S&T policies and socio-political constructs. Unfortunately there has been little attention paid to the consequences of these policy issues from which the research community has, by and large, been passenger rather than driver.]]></description></item></channel></rss>